Form 4 for AVIR Atea Pharmaceuticals, Inc.
Accepted 2024-06-18 00:00:00 ET · period of report 2024-06-16 · accession 0000950170-24-074986 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-18 | 2024-06-16 | AVIR | Polsky Bruce | Dir | M - OptEx | $0.00 | +33.1K | 83.2K | +66% | $0 |
| D | 2024-06-18 | 2024-06-16 | AVIR | Polsky Bruce | Dir | M - OptEx | $0.00 | -33.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-16 | M | A | 33,150 | $0.00 | 83,150 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2024-06-16 | M | D | 33,150 | $0.00 | 0 | D | — · — to — | 33,150 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The restricted stock units are fully vested. (F3) The restricted stock units do not have an expiration date. |